finasteride and Diabetes Mellitus

finasteride has been researched along with Diabetes Mellitus in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Culig, Z; Madersbacher, S; Sampson, N	1
Guay, AT; Traish, AM; Zitzmann, M	1
Bortolato, M; Garcia-Segura, LM; Melcangi, RC; Traish, AM; Zitzmann, M	1
Gausa Gascon, L; Millán Rodríguez, F; Palou Redorta, J; Salvador Bayarre, J; Segarra Tomás, J; Villavicencio Mavrich, H	1
Albanes, D; Chi, C; Gong, Z; Goodman, PJ; Hsing, AW; Kristal, AR; Lippman, SM; Neuhouser, ML; Platz, EA; Pollak, MN; Thompson, IM	1

Reviews

3 review(s) available for finasteride and Diabetes Mellitus

Article	Year
Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review. Gerontology, 2019, Volume: 65, Issue:5 Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aging; Diabetes Mellitus; Dihydrotestosterone; Dutasteride; Dyslipidemias; Finasteride; Humans; Inflammation; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Prostatic Hyperplasia; Receptors, Androgen	2019
5α-Reductase inhibitors alter steroid metabolism and may contribute to insulin resistance, diabetes, metabolic syndrome and vascular disease: a medical hypothesis. Hormone molecular biology and clinical investigation, 2014, Volume: 20, Issue:3 Topics: 5-alpha Reductase Inhibitors; Animals; Azasteroids; Diabetes Mellitus; Dutasteride; Finasteride; Glucocorticoids; Humans; Insulin Resistance; Metabolic Syndrome; Mineralocorticoids; Obesity; Vascular Diseases	2014
Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know? Reviews in endocrine & metabolic disorders, 2015, Volume: 16, Issue:3 Topics: 5-alpha Reductase Inhibitors; Alopecia; Animals; Central Nervous System; Cholestenone 5 alpha-Reductase; Cognition Disorders; Depression; Diabetes Mellitus; Dutasteride; Finasteride; Humans; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Psychoses, Substance-Induced; Sexual Dysfunction, Physiological; Steroids	2015

Trials

1 trial(s) available for finasteride and Diabetes Mellitus

Article	Year
Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2006, Volume: 15, Issue:10 Topics: Adenocarcinoma; Age Factors; Aged; Body Mass Index; Diabetes Mellitus; Enzyme Inhibitors; Finasteride; Humans; Logistic Models; Male; Middle Aged; Neoplasm Staging; Obesity; Prostatic Neoplasms; Research Design; Risk Factors; Waist-Hip Ratio	2006

Article

Year

Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2006, Volume: 15, Issue:10

Topics: Adenocarcinoma; Age Factors; Aged; Body Mass Index; Diabetes Mellitus; Enzyme Inhibitors; Finasteride; Humans; Logistic Models; Male; Middle Aged; Neoplasm Staging; Obesity; Prostatic Neoplasms; Research Design; Risk Factors; Waist-Hip Ratio

2006

Other Studies

1 other study(ies) available for finasteride and Diabetes Mellitus

Article	Year
[Efficacy of finasteride in the treatment of hematuria associated with benign prostatic hypertrophy]. Archivos espanoles de urologia, 2002, Volume: 55, Issue:8 Topics: 5-alpha Reductase Inhibitors; Aged; Comorbidity; Diabetes Mellitus; Enzyme Inhibitors; Finasteride; Hematuria; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia; Postoperative Complications; Prospective Studies; Prostatectomy; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Severity of Illness Index; Transurethral Resection of Prostate; Treatment Outcome; Vascular Diseases	2002

Article

Year

[Efficacy of finasteride in the treatment of hematuria associated with benign prostatic hypertrophy].

Archivos espanoles de urologia, 2002, Volume: 55, Issue:8

Topics: 5-alpha Reductase Inhibitors; Aged; Comorbidity; Diabetes Mellitus; Enzyme Inhibitors; Finasteride; Hematuria; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia; Postoperative Complications; Prospective Studies; Prostatectomy; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Severity of Illness Index; Transurethral Resection of Prostate; Treatment Outcome; Vascular Diseases

2002